Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1996-7-8
pubmed:abstractText
Chemotherapy intensification may lead to new forms of toxicity such as hemolytic uremic syndrome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Carmustine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, Intravenous, http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2338-42
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:8635040-Adult, pubmed-meshheading:8635040-Antimetabolites, Antineoplastic, pubmed-meshheading:8635040-Antineoplastic Agents, pubmed-meshheading:8635040-Antineoplastic Agents, Alkylating, pubmed-meshheading:8635040-Antineoplastic Agents, Phytogenic, pubmed-meshheading:8635040-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8635040-Bone Marrow Transplantation, pubmed-meshheading:8635040-Carboplatin, pubmed-meshheading:8635040-Carmustine, pubmed-meshheading:8635040-Cyclophosphamide, pubmed-meshheading:8635040-Cytarabine, pubmed-meshheading:8635040-Etoposide, pubmed-meshheading:8635040-Fatal Outcome, pubmed-meshheading:8635040-Female, pubmed-meshheading:8635040-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:8635040-Hemolytic-Uremic Syndrome, pubmed-meshheading:8635040-Humans, pubmed-meshheading:8635040-Hypertension, pubmed-meshheading:8635040-Immunoglobulins, Intravenous, pubmed-meshheading:8635040-Male, pubmed-meshheading:8635040-Middle Aged, pubmed-meshheading:8635040-Plasma, pubmed-meshheading:8635040-Remission Induction, pubmed-meshheading:8635040-Renal Insufficiency, pubmed-meshheading:8635040-Retinal Vein Occlusion, pubmed-meshheading:8635040-Thiotepa, pubmed-meshheading:8635040-Thrombocytopenia, pubmed-meshheading:8635040-Transplantation, Autologous, pubmed-meshheading:8635040-Vincristine
pubmed:year
1995
pubmed:articleTitle
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
pubmed:affiliation
Academic Medical Centre, University of Amsterdam, Department of Internal Medicine, Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Review, Case Reports